Ana Gallego-Lleyda

High-order TRAIL oligomer formation in TRAIL-coated lipid nanoparticles enhances DR5 cross-linking and increases antitumour effect against colon cancer

Diego de Miguel, Ana Gallego-Lleyda, José M. Ayuso et al. · Cancer Letters · 2016 · 55 citations

Nanomedicine, Nanotherapeutics, Engineering +9

Comparative proteomics of exosomes secreted by tumoral Jurkat T cells and normal human T cell blasts unravels a potential tumorigenic role for valosin-containing protein

Alberto Bosque, Lisa Dietz, Ana Gallego-Lleyda et al. · Oncotarget · 2016 · 52 citations · Full text

Liposome-bound TRAIL induces superior DR5 clustering and enhanced DISC recruitment in histiocytic lymphoma U937 cells

Diego de Miguel, Ana Gallego-Lleyda, Alberto Anel et al. · Leukemia Research · 2015 · 50 citations

Disc Recruitment, Cell Trafficking, Cell Interaction +7

TRAIL-coated lipid-nanoparticles overcome resistance to soluble recombinant TRAIL in non-small cell lung cancer cells

Diego de Miguel, Ana Gallego-Lleyda, José M. Ayuso et al. · Nanotechnology · 2016 · 39 citations

Immunotherapy with liposome-bound TRAIL overcomes partial protection to soluble TRAIL-induced apoptosis offered by down-regulation of Bim in leukemic cells

Diego de Miguel, Ana Gallego-Lleyda, Patricia Galán‐Malo et al. · Clinical & Translational Oncology · 2015 · 31 citations

Leukemic Cells, Apoptosis, Immunology +8